AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
76 hedge funds and large institutions have $116M invested in Agile Therapeutics in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $118M → $116M (-$2.06M)
Holders
76
Holding in Top 10
1
Calls
$641K
Puts
$214K
Top Buyers
| 1 | +$2M | |
| 2 | +$1.72M | |
| 3 | +$1.6M | |
| 4 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$595K |
| 5 |
Two Sigma Investments
New York
|
+$492K |
Top Sellers
| 1 | -$2.5M | |
| 2 | -$693K | |
| 3 | -$423K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$207K |
| 5 |
VF
Virtu Financial
New York
|
-$180K |